Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Washington

About this trial

Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on the spinal cord tissue and decreased spinal cord blood flow at the site of injury. The combination of increased pressure and decreased blood flow causes vascular hypoperfusion of the spinal cord and exacerbates the severity of injury. This is also referred to as secondary injury. Thus, knowledge of spinal cord hypoperfusion would allow the treating physician to optimize the hemodynamic condition of the patient with acute spinal cord injury and potentially improve functional outcomes.

Eligibility criteria

Qualifiers

18 years of age minimum

Acute spinal cord injury fpr less than 24 hours

Injury ranging from mild spinal cord injury where motor function is preserved (AIS A) to complete injury where there is no motor or sensory function below the leel of the injury (AIS D)

Medically stable to undergo routine dorsal decompression, spinal realignment

Disqualifiers

Younger than 18 years old

Neurological lower extremity exam missing or intact

Traumatic head injury with a Glasgow score of 11 or lower

Cord injury level caudal to T10 (thoracic spine level 10)

Trial design

Treatments tested in this trial

  • Perflutren lipid

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Washington

Lead sponsor

United States Department of Defense

Collaborator